Effects on biological behavior of bladder carcinoma T24 cells via silencing DNMT1 and/or DNMT3b with shRNA In Vitro

  • Shilong Zhang (张士龙)
  • Fuqing Zeng (曾甫清)
  • Shibo Peng (彭世波)
  • Chaohui Zhu (朱朝辉)
  • Heng Li (李恒)
  • Liang Wang (汪良)


In this study, RNA interference technique was employed to silence the expression of DNMT1 and/or DNMT3b in human bladder cancer T24 cells. The expression levels of their mRNA and protein were greatly decreased by up to 75% and 65% respectively after T24 cells were transfected with lipofectamine2000 for 72 h, indicating RNA interference is an effective tool in gene knockdown. Proliferation and apoptosis of T24 cells were detected by MTT, and annexin-V-FITC and propidium iodide staining flow cytometry, respectively. It was found that loss of the DNMT1 or DNMT3b expression could inhibit the cell growth and promote the cell apoptosis to some extent. However, combined treatment with shRNA targeting both DNMT1 and DNMT3b mRNA could obviously enhance the above effects. It was concluded that simultaneously silencing both genes could result in strong suppressing effect on tumor proliferation and promoting cell apoptosis than separate use, suggesting combined use of DNMT1 and DNMT3b can achieve a synergistic effect in the CpG island methylation in human bladder tumorigenesis.

Key words

DNMT1 DNMT3b apoptosis proliferation bladder cancer 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 1998,391(6669):806–811PubMedCrossRefGoogle Scholar
  2. 2.
    Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001,411(6836):494–498PubMedCrossRefGoogle Scholar
  3. 3.
    Waterhouse PM, Wang MB, Lough T. Gene silencing as an adaptive defence against viruses. Nature, 2001,411 (6839):834–842PubMedCrossRefGoogle Scholar
  4. 4.
    Szyf M, Detich N. Regulation of the DNA methylation machinery and its role in cellular transformation. Prog Nucleic Acid Res Mol Biol, 2001,69:47–79PubMedCrossRefGoogle Scholar
  5. 5.
    Kanai Y, Hirohashi S. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis, 2007,28(12):2434–2442PubMedCrossRefGoogle Scholar
  6. 6.
    Luczak MW, Jagodzinski PP. The role of DNA methylation in cancer development. Folia Histochem Cytobiol, 2006,44(3):143–154PubMedGoogle Scholar
  7. 7.
    Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet, 2000,9(16):2395–2402PubMedCrossRefGoogle Scholar
  8. 8.
    Margot JB, Ehrenhofer-Murray AE, Leonhardt H. Interactions within the mammalian DNA methyltransferase family. BMC Mol Biol, 2003,4(7):1471–1479Google Scholar
  9. 9.
    Wu JC, Santi DV. On the mechanism and inhibition of DNA cytosine methyltransferases. Prog Clin Biol Res, 1985,198:119–1929PubMedGoogle Scholar
  10. 10.
    Robertson KD, Uzvolgyi E, Liang G, et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res, 1999,27(11):2291–2298PubMedCrossRefGoogle Scholar
  11. 11.
    Nakagawa T, Kanai Y, Ushijiama S, et al. DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis. J Urol, 2005,173(5):1767–1771PubMedCrossRefGoogle Scholar
  12. 12.
    Etoh T, Kanai Y, Ushijiama S, et al. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol, 2004,164(2):689–699PubMedGoogle Scholar
  13. 13.
    Chen CL, Yan X, Gao YN, et al. Expression of DNA methyltransferase 1, 3A and 3B mRNA in the epithelial ovarian carcinoma. Zhonghua Fu Chan Ke Za Zhi (Chinese), 2005,40(11):770–774Google Scholar
  14. 14.
    Benbrahim-Tallaa L, Waterland RA, Dill AL, et al. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase. Environ Health Perspect, 2007,115(10):1454–1459PubMedGoogle Scholar
  15. 15.
    Fanelli M, Caprodossi S, Ricci-Vitiani L, et al. Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment. Oncogene, 2008,10:27 (3):358–365CrossRefGoogle Scholar
  16. 16.
    Szyf M. Targeting DNA methylation in cancer. Bull Cancer, 2006,93(9):961–972PubMedGoogle Scholar
  17. 17.
    Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol, 2003,4(6):351–358PubMedCrossRefGoogle Scholar
  18. 18.
    Kassis ES, Zhao M, Hong JA, et al. Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and eso-phageal cancer and malignant pleural mesothelioma cells. J Thorac Cardiovasc Surg, 2006,131(2):298–306PubMedCrossRefGoogle Scholar
  19. 19.
    Xiong Y, Dowdy SC, Xue A, et al. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. Gynecol Oncol, 2005, 96(3):601–609PubMedCrossRefGoogle Scholar
  20. 20.
    Robert MF, Morin S, Beaulieu N, et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet, 2003,33(1):61–65PubMedCrossRefGoogle Scholar
  21. 21.
    Leu YW, Ralunatpanah F, Shi H, et al. Double RNA interference of DNMT3b and DNMT1 enhances DNA de-methylation and gene reactivation. Cancer Res, 2003, 63(19):6110–6115PubMedGoogle Scholar
  22. 22.
    Rhee I, Jair KW, Yen RW, et al. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature, 2000,404(6781):1003–1007PubMedCrossRefGoogle Scholar

Copyright information

© Huazhong University of Science and Technology and Springer-Verlag GmbH 2009

Authors and Affiliations

  • Shilong Zhang (张士龙)
    • 1
  • Fuqing Zeng (曾甫清)
    • 1
  • Shibo Peng (彭世波)
    • 1
  • Chaohui Zhu (朱朝辉)
    • 1
  • Heng Li (李恒)
    • 1
  • Liang Wang (汪良)
    • 1
  1. 1.Department of Urology, Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations